rs547352394
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_052945.4(TNFRSF13C):c.191G>T(p.Gly64Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0103 in 1,488,228 control chromosomes in the GnomAD database, including 125 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Benignin ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G64S) has been classified as Uncertain significance.
Frequency
Consequence
NM_052945.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TNFRSF13C | NM_052945.4 | c.191G>T | p.Gly64Val | missense_variant | 2/3 | ENST00000291232.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TNFRSF13C | ENST00000291232.5 | c.191G>T | p.Gly64Val | missense_variant | 2/3 | 1 | NM_052945.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00714 AC: 1085AN: 152044Hom.: 6 Cov.: 32
GnomAD3 exomes AF: 0.00868 AC: 787AN: 90680Hom.: 14 AF XY: 0.00799 AC XY: 411AN XY: 51458
GnomAD4 exome AF: 0.0107 AC: 14316AN: 1336076Hom.: 119 Cov.: 33 AF XY: 0.0105 AC XY: 6934AN XY: 658982
GnomAD4 genome ? AF: 0.00712 AC: 1083AN: 152152Hom.: 6 Cov.: 32 AF XY: 0.00646 AC XY: 481AN XY: 74406
ClinVar
Submissions by phenotype
Immunodeficiency, common variable, 4 Uncertain:1Benign:3
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 07, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Jun 30, 2020 | The TNFRSF13C c.191G>T variant is classified as Likely Benign (BS1, BP6) - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Dec 31, 2019 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Aug 29, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | TNFRSF13C: BS1, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at